AR019404A1 - Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contiene - Google Patents
Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contieneInfo
- Publication number
- AR019404A1 AR019404A1 ARP990103485A ARP990103485A AR019404A1 AR 019404 A1 AR019404 A1 AR 019404A1 AR P990103485 A ARP990103485 A AR P990103485A AR P990103485 A ARP990103485 A AR P990103485A AR 019404 A1 AR019404 A1 AR 019404A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- independently
- substituted
- radicals
- methoxy
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 12
- 239000001257 hydrogen Substances 0.000 abstract 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 7
- -1 biphenylsulfonyl Chemical group 0.000 abstract 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 6
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 6
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de imidazol con sustitucion de bifenilsulfonilo, de la formula (1) en la cual: R1 representa hidrogeno, alquilo C1-8 o Ca-H2a-fenilo, estando laparte fenilo no sustituida o sustituida con 1, 2 o 3 radicales, iguales o distintos entre si, dela serie F, Cl, Br, I, CF3, metilo, metoxi, hidroxi o NR8R9;R8 y R9, independientemente entre si, representan hidrogeno o alquilo C1-4; a vale 0, 1 o 2; o R1 representa -CbH2b-heteroarilo C1-9, estando la parteheteroarilo no sustituida o sustituidacon 1, 2 o 3 radicales, iguales o diferentes entre si, de la serie F, Cl, Br, I, CF3, metilo, metoxi, hidroxi o NR10R11;R10 y R11, independientemente entre si, representan hidrogeno o alquilo C1-4; b vale 0, 1 o 2; o R1 representa -Cd-H2d-cicloalquilo C3-7; d vale 0, 1 o 2; R2 yR3, independientemente entre si, representan hidrogeno, F, Cl, Br, I, CF3, -CN, -NO2, CH2OR17, CO-R6 u O-R7; R17 representa hidrogeno o alquilo C1-8; R6representa hidrogeno, alquilo C1-8, OR30 o fenilo, no sustituido o sustituido con 1, 2 o 3 radicales, iguales o distintos entre si, de la serie F, Cl, Br, I,CF3, metilo, metoxi, hidroxi o NR31R32; R31 y R32, independientemente entre si, representan hidrogeno o alquilo C1-4; R30 representa hidrogeno o alquilo C1-8;R7 representa hidrogeno, alquilo C1-8 o fenilo no sustituido o sustituido con 1, 2 o 3 radicales, iguales o distintos entre si, de la serie F, Cl, Br, I, CF3,metilo, metoxi, hidroxi o NR12R13; R12 y R13, independientemente entre si, representan hidrogenoo alquilo C1-4; o R7 representa heteroarilo C1-9, nosustituido o sustituido con 1, 2 o 3 radicales, iguales o distintos entre si, de la serie F, Cl, Br, I, CF3, metilo, metoxi, hidroxi o NR14R15; R14 y R15,independientemente entre si, representan hidrogeno o alquilo C1-4; o R2 y R3, independientemente entre si, representan alquilo C1-8, cicloalquilo C3-8, o-Cg-H2g-fenilo, estando la parte fenilo no sustituida o sustituida con 1, 2 o 3 radicales, iguales o distintos entre si, de la serie F, Cl,Br, I, CF3, metilo,metoxi, hidroxi o NR18R19; R18 y R19, independientemente entre si, representan hidrogeno o alquilo C1-4; g vale 0, 1 o 2; o R2 y R3, independientemente entre
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19832429A DE19832429A1 (de) | 1998-07-18 | 1998-07-18 | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019404A1 true AR019404A1 (es) | 2002-02-20 |
Family
ID=7874575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103485A AR019404A1 (es) | 1998-07-18 | 1999-07-15 | Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contiene |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6372917B1 (es) |
| EP (1) | EP1097140B1 (es) |
| JP (1) | JP4567884B2 (es) |
| KR (1) | KR20010070984A (es) |
| CN (1) | CN1177827C (es) |
| AR (1) | AR019404A1 (es) |
| AT (1) | ATE260901T1 (es) |
| AU (1) | AU764784B2 (es) |
| BR (1) | BR9912139A (es) |
| CA (1) | CA2338039A1 (es) |
| DE (2) | DE19832429A1 (es) |
| DK (1) | DK1097140T3 (es) |
| ES (1) | ES2217779T3 (es) |
| HK (1) | HK1038352A1 (es) |
| HU (1) | HUP0103184A3 (es) |
| ID (1) | ID27023A (es) |
| MX (1) | MXPA01000534A (es) |
| PL (1) | PL346165A1 (es) |
| PT (1) | PT1097140E (es) |
| RU (1) | RU2246489C2 (es) |
| TR (1) | TR200100123T2 (es) |
| WO (1) | WO2000003994A2 (es) |
| ZA (1) | ZA200100318B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| KR20030024259A (ko) * | 2001-09-17 | 2003-03-26 | 주식회사케이텍정보통신 | 도로통행료 징수 시스템 |
| US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| DE10356717A1 (de) * | 2003-12-02 | 2005-07-07 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| EP0503838A3 (en) * | 1991-03-08 | 1992-10-07 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
| JP3290657B2 (ja) * | 1991-05-01 | 2002-06-10 | メルク エンド カムパニー インコーポレーテッド | アンギオテンシンｉｉ拮抗剤として活性な酸性アラルキルトリアゾール誘導体 |
| TW215434B (es) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| FR2711367B1 (fr) * | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2716882B1 (fr) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0855392A3 (de) | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-18 DE DE19832429A patent/DE19832429A1/de not_active Withdrawn
-
1999
- 1999-07-10 PL PL99346165A patent/PL346165A1/xx not_active Application Discontinuation
- 1999-07-10 ES ES99934669T patent/ES2217779T3/es not_active Expired - Lifetime
- 1999-07-10 JP JP2000560101A patent/JP4567884B2/ja not_active Expired - Fee Related
- 1999-07-10 PT PT99934669T patent/PT1097140E/pt unknown
- 1999-07-10 EP EP99934669A patent/EP1097140B1/de not_active Expired - Lifetime
- 1999-07-10 TR TR2001/00123T patent/TR200100123T2/xx unknown
- 1999-07-10 DE DE59908753T patent/DE59908753D1/de not_active Expired - Lifetime
- 1999-07-10 CA CA002338039A patent/CA2338039A1/en not_active Abandoned
- 1999-07-10 BR BR9912139-5A patent/BR9912139A/pt not_active IP Right Cessation
- 1999-07-10 CN CNB998086967A patent/CN1177827C/zh not_active Expired - Fee Related
- 1999-07-10 ID IDW20010128A patent/ID27023A/id unknown
- 1999-07-10 HU HU0103184A patent/HUP0103184A3/hu unknown
- 1999-07-10 DK DK99934669T patent/DK1097140T3/da active
- 1999-07-10 AT AT99934669T patent/ATE260901T1/de not_active IP Right Cessation
- 1999-07-10 US US09/743,941 patent/US6372917B1/en not_active Expired - Lifetime
- 1999-07-10 RU RU2001104454/04A patent/RU2246489C2/ru not_active IP Right Cessation
- 1999-07-10 WO PCT/EP1999/004886 patent/WO2000003994A2/de not_active Application Discontinuation
- 1999-07-10 AU AU50364/99A patent/AU764784B2/en not_active Ceased
- 1999-07-10 KR KR1020017000751A patent/KR20010070984A/ko not_active Application Discontinuation
- 1999-07-10 MX MXPA01000534A patent/MXPA01000534A/es not_active IP Right Cessation
- 1999-07-15 AR ARP990103485A patent/AR019404A1/es not_active Application Discontinuation
-
2001
- 2001-01-11 ZA ZA200100318A patent/ZA200100318B/en unknown
- 2001-12-27 HK HK01109111A patent/HK1038352A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1097140B1 (de) | 2004-03-03 |
| ES2217779T3 (es) | 2004-11-01 |
| KR20010070984A (ko) | 2001-07-28 |
| PL346165A1 (en) | 2002-01-28 |
| ID27023A (id) | 2001-02-22 |
| AU5036499A (en) | 2000-02-07 |
| EP1097140A2 (de) | 2001-05-09 |
| DK1097140T3 (da) | 2004-05-24 |
| WO2000003994A2 (de) | 2000-01-27 |
| BR9912139A (pt) | 2001-04-10 |
| CN1309644A (zh) | 2001-08-22 |
| US6372917B1 (en) | 2002-04-16 |
| ATE260901T1 (de) | 2004-03-15 |
| HUP0103184A2 (hu) | 2002-04-29 |
| DE19832429A1 (de) | 2000-01-20 |
| DE59908753D1 (de) | 2004-04-08 |
| AU764784B2 (en) | 2003-08-28 |
| HK1038352A1 (en) | 2002-03-15 |
| PT1097140E (pt) | 2004-07-30 |
| JP4567884B2 (ja) | 2010-10-20 |
| MXPA01000534A (es) | 2002-06-04 |
| HUP0103184A3 (en) | 2002-05-28 |
| JP2002520397A (ja) | 2002-07-09 |
| WO2000003994A3 (de) | 2000-04-20 |
| TR200100123T2 (tr) | 2001-05-21 |
| CA2338039A1 (en) | 2000-01-27 |
| ZA200100318B (en) | 2002-04-11 |
| CN1177827C (zh) | 2004-12-01 |
| RU2246489C2 (ru) | 2005-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8548001A1 (es) | Derivados aromaticos de acidos dicarboxilicos | |
| AR019404A1 (es) | Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contiene | |
| NO20015226D0 (no) | Tri-aryl syrederivater som PPAR reseptor ligander | |
| NO20002169L (no) | Nye pyridazinderivater og medikamenter inneholdende disse som effektive ingredienser | |
| NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
| MY132129A (en) | Polyarylcarboxamides useful as lipid lowering agents | |
| BG105467A (en) | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors | |
| ATE409189T1 (de) | Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate | |
| HUP0303193A2 (hu) | Ftalazinon-piperidin-származékok, mint PDE4-inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| NO20042534L (no) | Forbedringer vedrorende optiske lysgjoringsmidler | |
| DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
| NZ332990A (en) | oral pharmaceutical composition containing a H+, K+-atpase inhibitor having a extended blood plasma profile | |
| AR019405A1 (es) | Derivados de imidazol con sustitucion de bifenilsulfonilo, y preparacion farmaceutica que los contiene | |
| MX9205817A (es) | Derivados de benzodiazepina, procedimiento para supreparacion y medicamentos que los contienen | |
| DK0545845T3 (da) | Imidazolforbindelser, deres fremstilling og anvendelse som ca-kanal blokkere | |
| DE59908967D1 (de) | Indolinderivate als lichtschutzmittel | |
| NO954609L (no) | Niopecotiske syrederivater som antitrombiske forbindelser | |
| TR199902873T2 (xx) | Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri. | |
| AR015311A1 (es) | Compuestos diaril selenuros, composiciones farmaceuticas y composiciones cosmeticas que comprenden al menos uno de dichos compuestos y utilizacion de la composicion cosmetica | |
| ATE312830T1 (de) | 2,3-dihydro-1h-isoindol-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) | |
| TW200609289A (en) | Cellulose composition, cellulose film, and trialkoxy benzoic acid derivative compound | |
| AR023300A1 (es) | COMPUESTOS HETEROETINILENADOS, COMPOSICIONES FARMACÉUTICAS Y COSMÉTICAS QUE LOS COMPRENDEN Y UTILIZACIoN COSMÉTICA DE LA COMPOSICIoN COSMÉTICA PARA LA HIGIENE CORPORAL O CAPILAR. | |
| DK0850646T3 (da) | Liposompræparater af indolocarbazol-derivater | |
| ATE201402T1 (de) | Optisch aktive thiazolidinonderivate | |
| TR199902115T2 (xx) | 2,3- Dihidrofuro (3,2-b) piridiun t�revleri, haz�rlan��lar� ve terapide uygulanmalar�. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |